Search Results
Sep 15, 2025, 10:00 ET Glac Biotech erhält GRAS-Zulassung der US-Lebensmittel- und Arzneimittelbehörde für den Probiotikastamm CP-9
Zulassung unterstreicht die Sicherheit und Qualität von CP-9 Dem FDA-Antrag zufolge ist CP-9 für die Verwendung von bis zu 10⁹ koloniebildenden Einheiten (KBE) pro Portion in einer Vielzahl von Lebensmitteln und Getränken
More news about: Glac Biotech
Sep 15, 2025, 10:00 ET 글락바이오텍 프로바이오틱 균주 CP-9, FDA GRAS 승인 획득
승인은 CP-9의 안전성과 품질을 인정한 것 FDA 신고서에 따르면 CP-9는 다음과 같이 여러 식음료 제품에 1회분 당 10⁹ 콜로니 형성 단위(CFU)까지 사용 가능하다. 스포츠 및 에너지 음료강화수
More news about: Glac Biotech
Sep 15, 2025, 10:00 ET A GlacBiotech garante a aprovação da Administração de Alimentos e Medicamentos dos EUA (FDA) GRAS para a cepa probiótica CP-9
A aprovação destaca a segurança e a qualidade do CP-9 De acordo com o pedido da FDA, o CP-9 está autorizado para uso em níveis de até 10 unidades formadoras de colônias (UFCs) por porção em uma ampla gama de produtos
More news about: Glac Biotech
Sep 15, 2025, 10:00 ET Glac Biotech obtient l'approbation GRAS de la Food and Drug Administration des États-Unis pour la souche probiotique CP-9
L'homologation souligne la sécurité et la qualité du CP-9 Selon le dossier déposé auprès de la FDA, l'utilisation du CP-9 est autorisée à des niveaux allant jusqu'à 10⁹ unités formatrices de colonies (UFC) par portion dans une large
More news about: Glac Biotech
Sep 15, 2025, 10:00 ET Glac Biotech obtiene la aprobación GRAS de la Administración de Alimentos y Medicamentos de EE. UU. para la cepa probiótica CP-9
La aprobación destaca la seguridad y la calidad de CP-9 De acuerdo con la presentación de la FDA, CP-9 está autorizado para su uso en niveles de hasta 109 unidades formadoras de colonias (UFC) por porción en una amplia gama
More news about: Glac Biotech
Sep 15, 2025, 10:00 ET 豐華生技益生菌菌株CP-9榮獲美國食品藥品監督管理局GRAS認證
運動及能量飲料營養強化飲料瓶裝茶飲穀物製品乳製品及非乳製品營養棒糖果果汁大豆及植物蛋白產品嬰幼兒食品CP-9曾於2023年入圍NutraIngredients Awards，其腸道健康與免疫調節功能已獲研究驗證，本次FDA GRAS認證，進一步強化豐華的益生菌產品線，並有望與乳雙歧桿菌BB-12等國際廣泛應用的菌株相輔並行，共同推動嬰幼兒及家庭營養市場。 持續擴展的益生菌與後生元解決方案
More news about: 豐華生物科技
Sep 15, 2025, 08:00 ET Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting
Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider. cp-170363v4 INVEGA SUSTENNA®, INVEGA TRINZA®, INVEGA HAFYERA® IMPORTANT SAFETY INFORMATION INDICATIONS
More news about: Johnson & Johnson
Sep 12, 2025, 09:15 ET Velo Protocol, Lightnet, and OpenEden Form Joint Venture to Launch Treasury-as-a-Service and ASEAN Settlement Network
institutions, money transfer operators, and enterprises across Asia. Backed by leading investors including UOB, Seven Bank, and CP Group, Lightnet delivers secure and compliant payment rails that connect banks, fintechs, and decentralized finance platforms, enabling inclusive financial
More news about: Velo Labs Technology Ltd.
Sep 12, 2025, 09:10 ET Velo Protocol, Lightnet, and OpenEden Form Joint Venture to Launch Treasury-as-a-Service and ASEAN Settlement Network
institutions, money transfer operators, and enterprises across Asia. Backed by leading investors including UOB, Seven Bank, and CP Group, Lightnet delivers secure and compliant payment rails that connect banks, fintechs, and decentralized finance platforms, enabling
More news about: Velo Labs Technology Ltd.